Medication
Noromby
DIN 02506467 · Juno Pharma Canada Inc.
What it is
- Active ingredients
- Enoxaparin Sodium — 40 mg
- Form and routes
- Solution · Subcutaneous, Intravenous
- Schedule
- PRESCRIPTION
- Authorised since
- 2021-06-25
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Lovenox
- Lovenox With Preservative 300MG/3ML
- Lovenox
- Lovenox
- Lovenox
- Lovenox
- Noromby
- Noromby
- Noromby
- Noromby
- Inclunox
- Inclunox
- Inclunox
- Inclunox
- Inclunox
- Redesca
- Redesca
- Redesca
- Redesca
- Redesca
- Redesca
- Elonox
- Elonox
- Elonox
- Elonox
- Elonox
- Axberi
- Axberi
- Axberi
- Axberi
- Axberi
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
Watch this medication
Ontario Drug Benefit coverage
As of 31 July 2026General benefit Part III-A
Ontario lists this product as a general benefit under the Ontario Drug Benefit program — Part III-A of the Formulary/CDI. For someone eligible for ODB, it is covered without a drug-specific approval.
- What ODB pays per unit
- $6.5498
This is what the Ontario Drug Benefit program reimburses a pharmacy for one unit, as of 31 July 2026. A deductible and a co-payment sit on top of it and differ by program — ODB, the Trillium Drug Program and the seniors co-payment each work differently — so it is not the figure anyone is charged at a counter. It also says nothing about private, workplace or federal coverage.
Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.
How it is classified
- Anatomical main group
- Blood and blood-forming organs
- ATC code
- B01AB05
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of B01AB05, see the WHO ATC/DDD Index.
Recalls and safety alerts
As of 12 August 2026No Health Canada recall has been matched to this product.
This is not a statement that no recall exists for this medication. Health Canada’s recalls data carries no DIN and no company name, so notices are matched on wording alone — and 1,437 of the 2,306 drug notices in the feed could not be matched to any product at all. Check Health Canada’s own search before concluding anything.
Search Health Canada recalls for Noromby →
How RxMonitor matches recalls, and how often it fails
Source: Health Canada — Recalls and Safety Alerts. Data current as of 2026-08-12. Matched on product name, not on DIN — the feed carries none.